The effect of azoximer bromide (Polyoxidonium(®)) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study

por Efimov, Sergey V, Matsiyeuskaya, Natallia V, Boytsova, Olga V, Akhieva, Lyudmila Yu, Kvasova, Elena I, Harrison, Francisco, Karpova, Yulia S, Tikhonov, Anton, Khomyakova, Nadezhda F, Hardman, Tim, Rossi, Jean-François
Publicado 2021